Business · 09/09/2015Updated: 10/17/2026 · 1 min read
FDA Announces Guidance for Industry on Endocrine-Related Drug Toxicity Evaluation
Summary
The FDA has released a guidance document to help pharmaceutical companies determine when to conduct additional studies to assess potential endocrine-related toxicity in drugs, following standard toxicology tests.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →